Fact-checked by Grok 2 weeks ago

Gallbladder disease

Gallbladder disease encompasses a range of disorders affecting the gallbladder, a small, pear-shaped organ located beneath the liver that stores and concentrates bile, a digestive fluid produced by the liver to help break down fats.^[1] The most common type is cholelithiasis, or gallstones, which are hardened deposits of cholesterol, bilirubin, or other substances that form in the gallbladder when bile components become imbalanced.^[2] These stones can range in size from a grain of sand to a golf ball and may remain asymptomatic or lead to complications such as blockage of the bile ducts, causing pain or inflammation.^[2] Other notable conditions include cholecystitis, an inflammation of the gallbladder often triggered by gallstones obstructing the cystic duct, and rarer issues like gallbladder polyps, perforation, or cancer.^[3] Globally, gallstone disease affects 5-25% of adults, with higher rates in Western populations.^[4] As of 2020, gallbladder disease affects approximately 10 to 15 percent of adults in the United States, with higher prevalence among women, older individuals, and certain ethnic groups such as American Indians and Mexican Americans.^[2]^[5] Many cases are "silent," meaning they produce no symptoms and require no treatment, but symptomatic episodes often manifest as biliary colic—a sudden, intense pain in the upper right abdomen that may radiate to the back or shoulder, lasting from minutes to hours, typically after fatty meals.^[6] Additional symptoms can include nausea, vomiting, fever, jaundice, or changes in urine and stool color if a stone blocks bile flow.^[6] Complications from untreated disease may involve acute cholecystitis, pancreatitis, or cholangitis, potentially requiring urgent medical intervention.^[7] The primary causes of gallbladder disease stem from disruptions in bile composition or gallbladder function, such as excess cholesterol or bilirubin in bile, inadequate bile salts, or incomplete emptying of the gallbladder.^[6] Risk factors include obesity, rapid weight loss, high-fat or low-fiber diets, diabetes, and hormonal influences like estrogen from pregnancy or hormone replacement therapy.^[6] Genetic predisposition also plays a role, with family history increasing susceptibility.^[2] Diagnosis typically involves ultrasound imaging, blood tests, or other procedures to detect stones or inflammation, while treatment ranges from watchful waiting for asymptomatic cases to surgical removal of the gallbladder (cholecystectomy) for symptomatic or complicated disease, a procedure that is generally safe and allows normal life without the organ.^[8]

Anatomy and Physiology

Gallbladder Structure

The gallbladder is a pear-shaped, hollow organ located in the right upper quadrant of the abdomen, positioned in a fossa on the visceral surface of the liver, specifically beneath segments IV and V.^[9] It is partially covered by peritoneum on its inferior surface and adheres closely to the liver's undersurface without an intervening capsule, though extensions of Glisson's capsule may be present.^[9] The organ connects to the biliary system via the cystic duct, which joins the common hepatic duct to form the common bile duct.^[9] Structurally, the gallbladder consists of three main divisions: the fundus, body, and neck. The fundus forms the widest, rounded distal portion, often projecting beyond the inferior border of the liver.^[9] The body constitutes the central, elongated storage region, tapering proximally into the neck, which includes the infundibulum—a funnel-shaped area leading to the cystic duct.^[9] The neck may feature a slight inferior outpouching known as Hartmann's pouch, a normal anatomical variant.^[9] Histologically, the gallbladder wall comprises four layers: an inner mucosa lined by simple columnar epithelium with microvilli for absorption, a lamina propria of connective tissue, a muscularis layer of smooth muscle arranged in longitudinal, circular, and oblique fibers that facilitate contraction, and an outer serosa or adventitia.^[9] The serosa covers the peritonealized portions, while adventitia binds the organ to the liver where peritoneum is absent.^[9] The mucosa lacks villi or submucosa, and its folds allow for expansion during filling.^[9] The arterial blood supply arises primarily from the cystic artery, a branch of the right hepatic artery originating from the common hepatic artery.^[9] Venous drainage occurs via the cystic vein, which empties into the portal vein.^[10] Nerve innervation includes parasympathetic fibers from the hepatic branch of the vagus nerve, which promote contraction and secretion; sympathetic input from the celiac plexus, which inhibits these functions; and sensory fibers from the right phrenic nerve.^[9] In adults, the gallbladder measures approximately 7 to 10 cm in length and 4 cm in width at its widest point, with a capacity of 30 to 50 mL when distended.^[9]^[11] This structure enables the gallbladder to store and concentrate bile produced by the liver.^[9]

Physiological Functions

The gallbladder serves as a vital accessory organ in the digestive system, primarily responsible for storing, concentrating, and releasing bile to facilitate fat digestion. Produced by the liver at a rate of approximately 500 to 1000 mL per day, hepatic bile is initially dilute, containing about 97-98% water along with bile salts, phospholipids, cholesterol, and bilirubin. The gallbladder modifies this bile through active absorption processes, enhancing its efficiency for postprandial use.^[12] A key physiological function of the gallbladder is the concentration of bile, achieved by the absorption of water and electrolytes across its mucosal epithelium, which features numerous microvilli to maximize surface area. This process concentrates hepatic bile 5- to 10-fold, increasing the solid content from roughly 2-3% to about 10-12%, thereby optimizing storage and potency without precipitating components under normal conditions. The concentrated bile, rich in bile salts (up to 10% of total solids), is stored in the gallbladder, which has a capacity of 30 to 50 mL between meals, allowing for intermittent accumulation during fasting periods.^[12]^[13] Upon ingestion of a meal, particularly one containing fats or proteins, the duodenum releases cholecystokinin (CCK) from enteroendocrine I-cells in response to luminal stimuli. CCK binds to receptors on gallbladder smooth muscle, inducing contraction and ejection of the stored bile through the cystic duct into the common bile duct, ultimately delivering it to the duodenum for fat emulsification. Simultaneously, CCK promotes relaxation of the sphincter of Oddi, a muscular valve at the ampulla of Vater, ensuring coordinated bile flow into the small intestine without reflux. This mechanism enables the timely release of bile to aid in the solubilization of dietary lipids into micelles, enhancing their digestion and absorption by pancreatic lipases.^[12] Beyond immediate digestion, bile salts from the gallbladder contribute to broader physiological homeostasis through the enterohepatic circulation. Approximately 95% of bile salts are reabsorbed in the distal ileum via active transport and returned to the liver via the portal vein, where they are resecreted into bile, minimizing daily losses to about 0.2-0.6 g and conserving hepatic synthesis. This recycling not only supports efficient lipid emulsification but also facilitates the absorption of fat-soluble vitamins (A, D, E, and K) and helps maintain cholesterol balance by promoting its excretion in bile.^[14]

Etiology and Risk Factors

Pathogenic Mechanisms

Gallbladder disease often arises from disruptions in bile homeostasis, where an imbalance in bile composition promotes the formation of precipitates that can evolve into stones or sludge. Cholesterol supersaturation occurs when hepatic secretion of cholesterol exceeds the solubilizing capacity of bile acids and phospholipids, leading to phase separation and precipitation of cholesterol monohydrate crystals. This imbalance is exacerbated by reduced bile acid synthesis or increased cholesterol delivery to the liver, creating lithogenic bile that favors crystal formation.^[7] Once supersaturated, bile undergoes nucleation, a critical step where crystals aggregate into macroscopic stones. Mucin glycoproteins secreted by the gallbladder epithelium act as pronucleating agents, providing a scaffold that traps and promotes the adhesion of cholesterol crystals, accelerating stone growth. For pigment stones, bacterial infections play a key role; enteric bacteria such as Escherichia coli produce β-glucuronidase, which deconjugates bilirubin glucuronides, resulting in the precipitation of calcium bilirubinate salts.^[15]^[16] Gallbladder stasis further contributes to pathogenesis by prolonging contact between lithogenic components and the mucosal surface, allowing time for nucleation and growth. Impaired motility, often due to neural or hormonal dysregulation such as reduced cholecystokinin-mediated contraction, leads to incomplete emptying and bile retention, heightening the risk of stone formation. Biliary sludge represents an intermediate stage, consisting of viscous precipitates of cholesterol crystals, calcium salts, and mucin that form in stagnant bile and serve as precursors to gallstones.^[7]^[17] In inflammatory conditions like cholecystitis, bile stasis or obstructing stones irritate the gallbladder mucosa, triggering an acute inflammatory cascade. This involves the release of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6 from epithelial cells, which recruit neutrophils and cause vascular permeability changes, resulting in edema and wall thickening.^[18] Acalculous cholecystitis develops through distinct mechanisms independent of stones, primarily involving ischemia from hypoperfusion of the cystic artery, often in the context of trauma, major surgery, or systemic illnesses like sepsis. These conditions promote bile stasis and secondary bacterial overgrowth, leading to mucosal inflammation without calculi. Factors such as obesity can indirectly influence these processes by altering bile composition, though they are detailed elsewhere.^[19]

Modifiable and Non-Modifiable Risk Factors

Risk factors for gallbladder disease are categorized as non-modifiable, which are inherent and unchangeable, and modifiable, which can be altered through lifestyle or medical interventions. These factors influence the formation of gallstones and related conditions by affecting bile composition, gallbladder motility, and cholesterol saturation. Understanding this distinction aids in prevention strategies, particularly for modifiable elements.^[20] Non-modifiable risk factors encompass demographic, genetic, and ethnic predispositions. Female sex confers a nearly twofold increased risk compared to males, primarily due to estrogen's promotion of cholesterol saturation in bile during reproductive years.^[20] Age over 40 years heightens susceptibility, with incidence rising 4- to 10-fold in older adults owing to diminished gallbladder motility and altered bile acid metabolism.^[20] Family history elevates risk approximately fivefold, reflecting hereditary influences on bile lithogenicity.^[20] Genetic variants, such as those in the ABCG5/ABCG8 genes, impair cholesterol transport into bile, with the ABCG8 D19H polymorphism associated with an odds ratio of 1.78 for gallstone formation.^[21] Ethnicity plays a significant role, with higher prevalence among Native Americans (up to 64% in Pima women) and Hispanics, attributed to combined genetic and historical dietary factors.^[20]^[22] Modifiable risk factors include lifestyle and metabolic elements that can be targeted to reduce disease incidence. Obesity, particularly with BMI greater than 30 kg/m², increases risk through enhanced hepatic cholesterol secretion and insulin resistance, with hazard ratios up to 2.11 in women and relative risks of 6.0 for severe cases (BMI >32 kg/m²).^[23]^[20] Rapid weight loss exceeding 1.5 kg per week, often from very low-calorie diets or bariatric surgery, mobilizes stored cholesterol, leading to bile supersaturation and gallstone formation in 30% to 71% of cases.^[23]^[20] Diets high in saturated fats and low in fiber alter the bile acid pool, promoting cholesterol precipitation; conversely, higher fiber intake mitigates this risk.^[7]^[20] Diabetes mellitus, via insulin resistance, impairs gallbladder emptying and elevates gallstone risk, often compounded by metabolic syndrome.^[20] Prolonged fasting or parenteral nutrition induces gallbladder stasis by reducing contraction, fostering stone development.^[24] Hormonal influences, while partially tied to non-modifiable sex differences, include modifiable exposures such as pregnancy and exogenous hormones. Pregnancy raises risk through progesterone's inhibition of gallbladder motility and estrogen's elevation of biliary cholesterol, resulting in biliary sludge in 5% to 30% of cases and gallstones in about 5%.^[20] Oral contraceptives and menopausal hormone therapy similarly increase susceptibility via estrogen and progestin effects on bile saturation and motility.^[20]^[25] Additional modifiable factors involve physical activity and underlying conditions. A sedentary lifestyle diminishes gallbladder motility, heightening risk, whereas regular endurance exercise (e.g., 30 minutes five times weekly) offers protective effects.^[20] Hemolytic disorders, such as sickle cell disease, promote pigment stone formation by elevating unconjugated bilirubin levels from chronic red blood cell breakdown, though management of the primary condition can mitigate secondary risks.^[20] These factors contribute to cholesterol supersaturation in bile, a key precursor to gallstone pathogenesis.^[20]

Types of Gallbladder Diseases

Cholelithiasis refers to the formation of gallstones within the gallbladder, while choledocholithiasis describes stones present in the common bile duct.^[7] These concretions arise from imbalances in bile composition, leading to precipitation of solutes.^[7] Gallstones are classified primarily into cholesterol and pigment types. Cholesterol stones, which predominate in Western populations comprising 70-80% of cases, appear yellow and consist of more than 50% cholesterol, often with lesser amounts of bile salts, lecithin, and bilirubin.^[20] Pigment stones account for the remainder and are subdivided into black and brown variants; black pigment stones form from calcium bilirubinate due to chronic hemolysis or conditions like cirrhosis, while brown pigment stones typically develop in the bile ducts secondary to bacterial infection and bile stasis.^[7] In developed countries, cholelithiasis affects 10-15% of adults, with an estimated 20-25 million cases in the United States alone.^[20] The majority, 70-80%, remain asymptomatic, known as silent stones, and are often discovered incidentally during imaging for unrelated issues.^[20] Symptomatic cholelithiasis manifests as biliary colic, characterized by episodic, severe right upper quadrant pain due to transient cystic duct obstruction by a gallstone.^[2] If stones migrate into the bile ducts, they can lead to complications such as acute pancreatitis from obstruction of the pancreatic duct or ascending cholangitis from bacterial overgrowth.^[2] Such events may also precipitate inflammatory conditions like cholecystitis.^[2] For asymptomatic gallstones, management typically involves observation alone, given the low annual risk of developing complications or symptoms, estimated at 1-2%.^[26]

Cholecystitis and Inflammatory Conditions

Cholecystitis refers to inflammation of the gallbladder, primarily triggered by obstruction of the cystic duct, often by gallstones, leading to bile stasis and secondary bacterial infection.^[27] This condition encompasses acute and chronic forms, with acute cholecystitis representing a medical emergency that can progress to severe complications if untreated.^[28] Inflammatory processes in the gallbladder wall result from increased intraluminal pressure, ischemia, and microbial overgrowth, distinguishing these conditions from mere gallstone presence.^[27] Acute calculous cholecystitis, the most common form, arises from cystic duct obstruction by a gallstone, causing rapid bile accumulation and gallbladder distension.^[27] Symptoms typically include severe right upper quadrant pain that peaks 1-2 hours after fatty meals, accompanied by nausea, vomiting, and fever; the pain often persists beyond 6 hours, differentiating it from biliary colic.^[27] If untreated, it progresses to gangrene or perforation in 10-20% of cases, potentially leading to peritonitis or sepsis.^[29] Acute acalculous cholecystitis accounts for 5-10% of all acute cholecystitis cases and occurs predominantly in critically ill patients, such as those with trauma, severe burns, prolonged fasting, or mechanical ventilation.^[19] Unlike the calculous form, it stems from gallbladder stasis, hypoperfusion, and ischemia rather than mechanical obstruction, resulting in a high mortality rate of 30-50% due to delayed diagnosis and rapid necrosis.^[19] Chronic cholecystitis develops from recurrent episodes of low-grade inflammation due to repeated irritation by gallstones, leading to progressive wall thickening, fibrosis, and impaired gallbladder contractility.^[30] Patients experience intermittent dull pain in the right upper quadrant, exacerbated by fatty foods, with bloating and nausea over weeks to months; over time, adhesions and smooth muscle hypertrophy may cause a shrunken, fibrotic gallbladder.^[30] Epidemiologically, 90-95% of cholecystitis cases are calculous, with an overall annual incidence of approximately 60 per 100,000 in developed countries, though rates rise in high-risk groups like women, the obese, and those over 40.^[27]^[31] Pathologically, cholecystitis advances through stages: initial edema from distension (2-4 days post-obstruction), followed by suppuration with pus formation and bacterial invasion, and ultimately necrosis with potential gangrene. Clinical examination often reveals Murphy's sign, where inspiration during right upper quadrant palpation elicits sharp pain due to inflamed peritoneal irritation.^[27]

Other Gallbladder Pathologies

Biliary dyskinesia, also known as functional gallbladder disorder, is a motility disorder characterized by impaired gallbladder emptying in the absence of structural abnormalities such as gallstones or inflammation. It typically presents with recurrent biliary-type pain, often mimicking post-cholecystectomy symptoms, including right upper quadrant discomfort exacerbated by fatty meals. Diagnosis relies on hepatobiliary iminodiacetic acid (HIDA) scintigraphy with cholecystokinin stimulation, where an ejection fraction below 35% indicates abnormal gallbladder function.^[32]^[33] Cholecystectomy may be considered for symptomatic cases with confirmed low ejection fraction, though outcomes vary due to the functional nature of the condition.^[34] Gallbladder polyps are benign protrusions from the gallbladder mucosa, most commonly cholesterol polyps or adenomyomatosis, detected incidentally in 5-10% of abdominal ultrasounds. These lesions are usually asymptomatic and non-neoplastic, but size serves as a key indicator for malignancy risk; polyps exceeding 1 cm warrant further evaluation due to a higher likelihood of adenomatous or malignant transformation.^[35]^[36] Endoscopic ultrasound or cholecystectomy is recommended for suspicious features, such as rapid growth or vascularity, to mitigate the rare but serious potential for progression to adenocarcinoma.^[37] Gallbladder cancer is a rare malignancy with an incidence of approximately 1-2 cases per 100,000 people in developed countries, increasing to 10-30 per 100,000 in high-risk populations such as those in South America and Asia, predominantly adenocarcinoma accounting for over 90% of cases. It often arises in the setting of chronic inflammation or long-standing gallstones, leading to metaplasia and dysplasia over time. The prognosis is poor, particularly for advanced stages, with a 5-year survival rate below 5% due to late diagnosis and aggressive local invasion.^[38]^[39] Early detection during cholecystectomy for benign disease offers the best outcomes, emphasizing the importance of vigilant monitoring in at-risk individuals.^[40] Congenital anomalies of the gallbladder encompass structural malformations present from birth, such as agenesis or septations, which are typically incidental findings during imaging for unrelated issues. Gallbladder agenesis occurs in approximately 0.1% of the population and may remain asymptomatic, though some cases manifest with biliary colic or jaundice due to aberrant bile drainage. Septations, involving incomplete division of the gallbladder cavity, are rarer and generally benign but can predispose to stone formation or mimic other pathologies on ultrasound.^[41]^[42] Management is conservative unless symptoms arise, with surgical intervention reserved for complications.^[43] Post-cholecystectomy syndrome refers to the persistence or recurrence of biliary symptoms in 10-40% of patients following gallbladder removal, often attributable to sphincter of Oddi dysfunction or retained ductal stones. Sphincter dysfunction, classified into types based on pain and enzyme levels, results from spasm or stenosis at the ampulla of Vater, leading to biliary stasis and pain. Diagnostic approaches include endoscopic retrograde cholangiopancreatography or manometry to confirm elevated sphincter pressures.^[44] Treatment may involve sphincterotomy for confirmed cases, highlighting the need for thorough preoperative evaluation to minimize this syndrome.^[45]

Signs and Symptoms

Acute Presentations

Acute presentations of gallbladder disease typically manifest as sudden and intense symptoms that demand prompt medical evaluation, often stemming from gallstone-related obstructions in the biliary system. These episodes can range from self-limiting pain to severe inflammatory or obstructive crises, distinguishing them from milder or prolonged manifestations. The most common acute scenarios include biliary colic, acute cholecystitis, and choledocholithiasis, each characterized by distinct symptom profiles that guide clinical urgency.^[46] Biliary colic represents the initial acute presentation in many cases, triggered by transient gallstone impaction in the cystic duct. Patients experience episodic, severe pain in the right upper quadrant (RUQ) of the abdomen, lasting from 30 minutes to several hours, which may radiate to the back or right shoulder.^[6]^[47] This pain is frequently precipitated by ingestion of fatty meals, which stimulate gallbladder contraction against the obstruction, and is typically unaccompanied by fever or jaundice.^[6] Nausea and vomiting may occur but resolve with the pain episode.^[48] In contrast, acute cholecystitis arises when the obstruction persists, leading to gallbladder inflammation and more severe symptoms. The hallmark is constant RUQ pain exceeding 6 hours in duration, often accompanied by fever greater than 38°C, nausea, and vomiting.^[27]^[49] Physical examination may elicit a positive Murphy's sign, where palpation of the RUQ during deep inspiration causes abrupt pain and inspiratory arrest due to inflamed gallbladder contact with the hand.^[27] This condition requires urgent intervention to prevent progression to complications like perforation.^[50] Choledocholithiasis, involving gallstone migration into the common bile duct, presents with obstructive symptoms that escalate the acuity. Key signs include jaundice, dark urine, and pale stools resulting from biliary stasis and bilirubin elevation.^[46] In approximately 50-70% of cases complicated by ascending cholangitis, patients exhibit Charcot's triad: RUQ pain, fever, and jaundice, signaling a potentially life-threatening infection.^[51]^[52] Overall, acute events occur in about 1-2% of patients with symptomatic gallstones annually, underscoring the need for vigilance in at-risk individuals.^[53] The intensity and persistence of pain serve as critical differentiators: brief, resolving episodes like biliary colic may warrant outpatient management, whereas prolonged pain with systemic signs, as in cholecystitis or choledocholithiasis, necessitates emergency care to avert severe outcomes.^[27]

Chronic and Atypical Manifestations

Chronic cholecystitis manifests as ongoing gallbladder inflammation leading to persistent symptoms such as indigestion, bloating, and flatulence after meals, often accompanied by intolerance to fatty foods and a dull discomfort in the right upper quadrant (RUQ) of the abdomen. This discomfort may radiate to the mid-back or right shoulder and typically lasts for about 30 minutes, distinguishing it from more acute episodes. Nausea, with or without occasional vomiting, frequently occurs, particularly in response to meals.^[30] Atypical presentations of gallbladder disease can include epigastric pain that mimics peptic ulcer disease or referred pain to the left upper quadrant or lower abdomen, complicating diagnosis.^[54] In elderly patients and those with diabetes mellitus, symptoms are often vague or minimal, such as nonspecific abdominal discomfort, which heightens the risk of undetected complications like perforation despite the absence of pronounced pain.^[55]^[56] Functional gallbladder disorders, such as biliary dyskinesia, involve intermittent biliary-type pain without evidence of gallstones, often triggered by meals and characterized by abnormal gallbladder motility.^[57] These symptoms may include right upper quadrant or epigastric pain accompanied by nausea, reflecting dysregulated bile flow rather than structural pathology.^[34] In pediatric cases, gallbladder disease may present with jaundice due to associated hemolytic conditions or obstruction, alongside abdominal pain and nausea.^[58] Among elderly individuals, manifestations can include anorexia and unintentional weight loss, contributing to delayed recognition of the underlying gallbladder pathology.^[59]

Diagnosis

Imaging Techniques

Imaging techniques play a crucial role in the diagnosis of gallbladder disease by providing structural and functional visualization of the gallbladder and biliary tract, enabling confirmation of abnormalities such as stones, inflammation, and obstructions.^[3] These methods range from noninvasive options like ultrasound to more advanced imaging such as magnetic resonance cholangiopancreatography (MRCP) and nuclear scintigraphy, selected based on clinical suspicion and the need to assess complications.^[60] Ultrasound serves as the first-line imaging modality for suspected gallbladder disease due to its high sensitivity (>95%) and specificity (>95%) for detecting gallstones larger than 2 mm, as well as its ability to identify gallbladder wall thickening greater than 3 mm, pericholecystic fluid, and sludge in conditions like cholelithiasis and cholecystitis.^[61]^[62] The sonographic Murphy's sign, elicited by focal tenderness over the gallbladder during probe compression, further supports the diagnosis of acute cholecystitis with a positive predictive value approaching 92%.^[3] As a noninvasive procedure without ionizing radiation, ultrasound is particularly advantageous for initial evaluation in outpatient and emergency settings.^[60] Computed tomography (CT) scan is valuable for evaluating complications in gallbladder disease, such as perforation, abscess formation, or gangrenous cholecystitis, with a reported sensitivity of 92.5% for acute cholecystitis.^[63] Contrast-enhanced CT excels in detecting ischemic changes and acalculous cholecystitis, achieving 80-90% sensitivity, and provides detailed assessment of surrounding structures when ultrasound findings are inconclusive.^[3] However, it is less sensitive than ultrasound for uncomplicated cholelithiasis due to potential oversight of non-calcified stones.^[60] Magnetic resonance imaging (MRI) and MRCP offer noninvasive evaluation of the biliary system, particularly for detecting ductal stones and strictures with approximately 90% accuracy, making them useful when ultrasound cannot adequately visualize the bile ducts.^[64] For acute cholecystitis, MRI demonstrates a sensitivity of 85% and specificity of 81%, comparable to ultrasound in some contexts.^[64] Endoscopic ultrasound (EUS) complements these by identifying small stones, polyps, or early neoplasms with high resolution, though it is more invasive and reserved for targeted cases.^[3] Hepatobiliary iminodiacetic acid (HIDA) scan, or cholescintigraphy, assesses gallbladder function and cystic duct patency, showing 95% sensitivity for detecting obstruction in acute cholecystitis through nonvisualization of the gallbladder after radiotracer injection.^[3] It is particularly indicated when ultrasound is equivocal, with an ejection fraction below 35% signaling biliary dyskinesia or chronic acalculous cholecystitis.^[3] This functional imaging avoids radiation concerns associated with CT while providing dynamic insights.^[60] Endoscopic retrograde cholangiopancreatography (ERCP) combines diagnostic and therapeutic capabilities for biliary and pancreatic duct evaluation, serving as a gold standard for confirming ductal stones or strictures in gallbladder-related disorders.^[60] It allows direct visualization and intervention, such as stone extraction, but is invasive with risks including pancreatitis, limiting its use to cases where therapeutic action is anticipated.^[3]

Laboratory and Functional Tests

Laboratory and functional tests play a crucial role in evaluating suspected gallbladder disease, particularly to detect inflammation, infection, biliary obstruction, and associated complications like pancreatitis or malabsorption. These tests complement imaging modalities by providing objective biomarkers of hepatic and systemic involvement. Blood-based assessments are typically the first line, focusing on liver function, inflammatory responses, and microbial evidence. Liver function tests (LFTs) often reveal abnormalities indicative of biliary obstruction or inflammation. In cases of obstruction, such as choledocholithiasis complicating cholecystitis, direct (conjugated) bilirubin levels are elevated due to impaired bile excretion.^[65] Alkaline phosphatase (ALP) is markedly increased, commonly 2-3 times the upper limit of normal in acute cholangitis, reflecting cholestasis.^[66] Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) show mild elevations in acute cholecystitis, usually less than five times the upper limit, suggesting transient hepatocellular injury from inflammation or pressure.^[67] Inflammatory markers help gauge the severity of gallbladder inflammation. Leukocytosis, with white blood cell counts typically ranging from 10,000 to 20,000/μL, is common in acute presentations like cholecystitis, driven by neutrophilic predominance.^[68] C-reactive protein (CRP) levels exceeding 30 mg/L signal significant inflammation and support the diagnosis of acute cholecystitis when combined with clinical findings.^[69] Blood cultures are recommended in suspected ascending cholangitis to identify causative pathogens, with positivity rates of 20-30% revealing polymicrobial infections such as Escherichia coli or Enterococcus.^[70] Amylase and lipase levels are measured to exclude concurrent gallstone-induced pancreatitis, where elevations greater than three times the upper limit may occur if a stone migrates to the pancreatic duct.^[71] Functional tests assessing bile acid metabolism have limited routine application in gallbladder disease but may evaluate post-cholecystectomy malabsorption or chronic complications. Serum bile acid levels can indicate disrupted enterohepatic circulation, while fecal fat quantification detects steatorrhea from bile salt deficiency, though these are not primary diagnostic tools.^[72]

Treatment and Management

Surgical Interventions

Surgical interventions for gallbladder disease primarily involve cholecystectomy, the removal of the gallbladder, which is indicated for symptomatic cholelithiasis, acute cholecystitis, and certain complicated cases such as those with gallbladder perforation or empyema.^[73] Laparoscopic cholecystectomy has emerged as the gold standard procedure, accounting for approximately 90% of cholecystectomies performed worldwide due to its minimally invasive nature and favorable outcomes.^[74] This technique involves four small incisions in the abdomen through which a camera and specialized instruments are inserted to dissect and remove the gallbladder, typically completing the operation in 30 to 60 minutes under general anesthesia.^[73] It achieves a success rate exceeding 95% in elective settings, with conversion to open surgery occurring in less than 5% of cases, often due to anatomical challenges or severe inflammation.^[75] Open cholecystectomy remains necessary in 5-10% of cases, particularly when severe adhesions, extensive inflammation, or prior abdominal surgeries complicate the laparoscopic approach, requiring a larger incision below the rib cage for direct access.^[73] Recovery from open surgery is more protracted, with patients typically hospitalized for 2-3 days and requiring 4-6 weeks for full resumption of normal activities, compared to 1-2 weeks for laparoscopic procedures.^[74] For high-risk patients with acute acalculous cholecystitis who are poor surgical candidates due to comorbidities, percutaneous cholecystostomy provides a temporizing drainage option, involving image-guided insertion of a catheter into the gallbladder to relieve pressure and infection.^[76] This procedure is effective in resolving symptoms in up to 90% of such cases and serves as definitive treatment in over 50%, avoiding the need for cholecystectomy in frail individuals.^[77] Endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is employed for managing choledocholithiasis, either preoperatively to clear common bile duct stones or postoperatively if residual stones are detected, achieving stone removal success rates of 85-95%.^[78] During ERCP, an endoscope is advanced through the mouth to the duodenum, where a sphincterotomy incision facilitates stone extraction via baskets or balloons. Timing of surgical intervention is critical: for acute cholecystitis, guidelines recommend urgent cholecystectomy within 72 hours of symptom onset to minimize complications and hospital stay, while chronic symptomatic cases are managed electively.^[79] Early intervention within 24-72 hours is associated with lower conversion rates and reduced length of stay compared to delayed surgery.^[80]

Non-Surgical Approaches

For patients with asymptomatic gallstones, watchful waiting is the preferred approach, as the annual risk of developing symptoms is low, ranging from 1% to 4%, and complications such as acute cholecystitis occur in only 0.1% to 0.3% of cases per year.^[81] This strategy avoids unnecessary intervention in the majority of cases, where up to 80% of individuals remain symptom-free over extended periods.^[82] Medical dissolution therapy with ursodeoxycholic acid (UDCA) is indicated for small, non-calcified cholesterol gallstones less than 1 cm in diameter in patients with a functioning gallbladder who are poor surgical candidates or prefer non-invasive options.^[83] UDCA works by reducing cholesterol saturation in bile and promoting stone dissolution, achieving success rates of 30% to 50% over 6 to 24 months of treatment at doses of 8 to 10 mg/kg daily.90870-7/abstract) It is also used adjunctively to prevent gallstone recurrence following extracorporeal shock wave lithotripsy (ESWL).^[84] Pain management for biliary colic episodes focuses on nonsteroidal anti-inflammatory drugs (NSAIDs) as first-line therapy, such as diclofenac 50 to 75 mg intramuscularly, which provides effective analgesia comparable to opioids while reducing the risk of progression to acute cholecystitis.^[81] For severe acute pain, opioids like buprenorphine may be employed, and antispasmodics such as hyoscine butylbromide can be added to relieve smooth muscle spasms in the biliary tract.^[85] These measures are typically used in outpatient settings for mild, uncomplicated cases. In acute cholecystitis, particularly for high-risk patients unsuitable for immediate surgery, intravenous antibiotics are administered empirically to cover enteric gram-negative bacteria and anaerobes, such as ceftriaxone 1 to 2 g daily combined with metronidazole 500 mg every 8 hours, for a duration of 7 to 14 days depending on clinical response and severity.^[86] This conservative approach aims to control infection and inflammation while monitoring for resolution. Extracorporeal shock wave lithotripsy (ESWL) is rarely utilized today but may be considered for select patients with a single symptomatic gallstone less than 2 cm who cannot undergo surgery, often combined with UDCA to fragment and dissolve the stone, yielding stone-free rates of around 55% in appropriately selected cases.^[81] Its use has declined due to high recurrence rates exceeding 40% within 4 years and the availability of more effective alternatives.^[83] Lifestyle modifications play a supportive role in managing symptoms and reducing stone formation risk, including adoption of a low-fat diet to minimize gallbladder stimulation and promote bile flow, alongside weight management through gradual loss and increased physical activity to lower overall biliary disease progression.^[87] These changes, such as limiting dietary fat to less than 30% of calories, can help alleviate colic frequency in mild cases.^[83] Modification of modifiable risk factors, like obesity and sedentary behavior, further supports long-term symptom control.^[81]

Complications and Prognosis

Immediate Complications

Immediate complications of gallbladder disease encompass acute adverse events arising directly from the pathology or its therapeutic interventions, such as perforation, infection escalation, and procedural mishaps. These events demand prompt recognition to mitigate risks like peritonitis or sepsis, often through vigilant monitoring and timely escalation to antibiotics or surgery. Gallbladder perforation occurs in approximately 2-11% of cases of acute cholecystitis, representing a critical progression where the inflamed gallbladder wall ruptures, leading to bile leakage and potentially life-threatening peritonitis.^[88] Empyema, characterized by pus accumulation within the gallbladder due to suppurative infection, arises as a severe extension of untreated acute cholecystitis, with reported incidences ranging from 2-11% and heightened mortality risk if not addressed surgically.^[89] Mirizzi syndrome, a rarer immediate complication, involves extrinsic compression of the common hepatic or bile duct by an impacted gallstone in the cystic duct or gallbladder neck, occurring in 0.3-1.4% of cholecystectomy cases and causing obstructive jaundice or cholangitis.^[90] Untreated associated cholangitis carries a high risk of progression to sepsis, manifesting as systemic infection with high mortality if biliary drainage is delayed; the severe form, known as Reynolds pentad, combines Charcot's triad (fever, jaundice, right upper quadrant pain) with hypotension and altered mental status, indicating septic shock.^[91] Gallstone migration through the common bile duct may also trigger acute pancreatitis, accounting for 40-70% of acute pancreatitis episodes worldwide.^[92] Treatment-related immediate complications primarily stem from cholecystectomy, the standard intervention. Bile duct injury during laparoscopic cholecystectomy affects about 0.5% of procedures, potentially causing strictures, bile stasis, or recurrent cholangitis if unrecognized intraoperatively.^[93] Bile leaks, occurring in 1-2% of cases, result from cystic duct stump disruption or accessory duct injury, leading to intra-abdominal collections that may require endoscopic stenting or drainage.^[94] Postoperative wound infections complicate 1-2% of laparoscopic cases, though rates are lower than in open surgery (up to 8%), and are managed with antibiotics to prevent deeper abscess formation.^[95] Early administration of broad-spectrum antibiotics combined with timely surgical intervention significantly reduces mortality in acute cholecystitis and cholangitis from historical rates of around 10% in untreated or delayed cases to less than 1% with prompt management, underscoring the importance of risk stratification using tools like the Tokyo Guidelines for prevention.^[96]

Long-Term Outcomes

Following cholecystectomy, the majority of patients experience significant symptom resolution, with 85-90% reporting relief from biliary pain and related discomfort.^[97] However, 10-15% may develop post-cholecystectomy syndrome, characterized by persistent or new symptoms such as abdominal pain or dyspepsia. Additionally, 10-20% of patients encounter chronic diarrhea attributable to bile acid malabsorption, where continuous bile flow into the intestine overwhelms colonic absorption; this condition is effectively managed with bile acid binders like cholestyramine.^[44]^[98] Recurrence risks vary by treatment modality. For non-surgical approaches like ursodeoxycholic acid dissolution, gallstone recurrence occurs in 10-20% of cases within the first few years post-treatment, primarily due to residual gallbladder function and stone reformation.^[99] In contrast, surgical cholecystectomy, when complete, yields recurrence rates below 5%, as the gallbladder is removed, eliminating the primary site for stone formation.^[82] Gallbladder cancer, often detected incidentally during 0.3-3% of cholecystectomies, carries stage-dependent long-term prognosis. Early-stage incidental findings (T1 or less) achieve 5-year survival rates of 60-80% with cholecystectomy alone, reflecting favorable outcomes from prompt intervention. Advanced stages, however, confer 5-year survival below 10%, underscoring the impact of delayed diagnosis.^[100]^[101] Quality-of-life impacts post-resolution are generally positive, with most patients resuming a normal diet and daily activities without restrictions. Nonetheless, 5-10% experience persistent dyspepsia, contributing to ongoing gastrointestinal discomfort and reduced well-being.^[97] Overall mortality from gallbladder disease remains low at under 1% for uncomplicated cases, enabling excellent long-term survival with timely management. In contrast, acalculous cholecystitis, particularly in intensive care settings, is associated with mortality up to 50%, driven by comorbidities and delayed recognition.^[102]^[102] Long-term follow-up emphasizes monitoring for residual risks, including annual imaging for gallbladder polyps exceeding 6 mm to detect potential malignant transformation. Lifestyle modifications, such as weight management and dietary adjustments, are recommended to prevent formation of new stones in the biliary tract.^[35]

References

[1]
Gallbladder Disease | MedlinePlus
### Summary of Gallbladder Disease (MedlinePlus)
[2]
Definition & Facts for Gallstones - NIDDK
Overview of gallstones, hard particles of cholesterol or bilirubin that your gallbladder makes. You need treatment right away if gallstones cause pain.<|control11|><|separator|>
[3]
Gallbladder Imaging - StatPearls - NCBI Bookshelf
The most common form of gallbladder disease is chronic cholecystitis with cholelithiasis. Up to 15% of the United States population has asymptomatic gallstones.
[4]
Symptoms & Causes of Gallstones - NIDDK
### Summary of Gallstones and Gallbladder Disease
[5]
Gallstones (Cholelithiasis) - StatPearls - NCBI Bookshelf - NIH
Jun 2, 2025 · Gallstones are crystallized deposits forming in the gallbladder or biliary tree, primarily composed of cholesterol, bilirubin, and bile.
[6]
Gallstones - Diagnosis & treatment - Mayo Clinic
Gallstones are hard pieces of material that can form in your gallbladder. Learn about causes and treatment for this sometimes painful digestive disorder.Symptoms & causes · Cholecystectomy (gallbladder... · Doctors and departments
[7]
Anatomy, Abdomen and Pelvis: Gallbladder - StatPearls - NCBI - NIH
The gallbladder is a pear-shaped organ in the right upper quadrant of the abdomen (see Image. The Gallbladder and Bile Ducts Laid Open).
[8]
The Cystic Vein: The Significance of a Forgotten Anatomic Landmark
The Textbook of Surgery edited by Sabiston reports only that the venous drainage of the gallbladder and extrahepatic ducts is into the portal vein.” ...
[9]
Cholecystomegaly: A Case Report and Review of the Literature - PMC
Aug 20, 2020 · The gallbladder is a pear-shaped sac that measures around 7 to 10 cm long and 4 cm wide, with an average capacity of 30 to 50 mL. When ...
[10]
Physiology, Gallbladder - StatPearls - NCBI Bookshelf
May 1, 2023 · Cholelithiasis is the term for gallstones in the gallbladder. The stones form as a result of imbalances in the constituents of bile and in ...
[11]
Diversification of host bile acids by members of the gut microbiota
Within the gallbladder, bile is concentrated 5–10 times, via removal of water and electrolytes, and acidified via Na+/H+ exchangers. Only about 50% of bile ...
[12]
Physiology, Bile Secretion - StatPearls - NCBI Bookshelf
Bile is a physiological aqueous solution produced and secreted by the liver. It consists mainly of bile salts, phospholipids, cholesterol, conjugated bilirubin ...
[13]
Gallbladder Mucin Plays a Role in Gallstone Formation - PubMed
Mucin is a high-molecular-weight glycoprotein that is synthesized, stored, and secreted by epithelial mucosal cells, especially goblet cells.
[14]
Pigment gallstone pathogenesis: slime production by biliary bacteria ...
Pigment stones are thought to form as a result of deconjugation of bilirubin by bacterial beta-glucuronidase, which results in precipitation of calcium ...
[15]
Physiology and pathophysiology of gallbladder motility - PubMed
Most significant gallbladder disease is associated with gallbladder stasis. Gallbladder motility is controlled by a complex interplay of hormonal and neural ...
[16]
Roles of Infection, Inflammation, and the Immune System in ... - NIH
The biliary epithelium clearly participates in cellular and humoral immunity through antigen presentation, cytokine and chemokine production, and Ig transport.Biliary Epithelium And... · Mucin Glycoproteins · Gallbladder Inflammation
[17]
Acalculous Cholecystitis - StatPearls - NCBI Bookshelf - NIH
Jun 15, 2025 · Acute acalculous cholecystitis is a severe, life-threatening inflammation of the gallbladder that occurs in the absence of gallstones.
[18]
Epidemiology of Gallbladder Disease: Cholelithiasis and Cancer - NIH
Other than ethnicity and female gender, additional risk factors for gallbladder cancer include cholelithiasis, advancing age, chronic inflammatory conditions ...
[19]
Genetics of Gallstone Disease and Their Clinical Significance - NIH
Feb 8, 2024 · This review aims to discuss the known genetic causes of GS disease, including hepatic, biliary, and hematopoietic abnormalities.Missing: modifiable | Show results with:modifiable
[20]
Sex and ethnic/racial-specific risk factors for gallbladder disease
Dec 8, 2017 · Overall, dietary, reproductive and obesity-related factors are strong risk factors for GBD affecting men and women of different ethnicities/races.
[21]
Obesity and Gallstones - PMC - PubMed Central - NIH
Rapid weight loss, defined as reduction of ≥1.5 kg of weight per week, by a very low-calorie diet or after bariatric surgery causes the formation of gallstones ...Missing: sedentary | Show results with:sedentary
[22]
Gallstones - PMC - PubMed Central - NIH
In fasting associated with severely fat restricted diets, gallbladder contraction is reduced, and the accompanying gallbladder stasis favors gallstone formation ...
[23]
Oral contraceptives and the risk of gallbladder disease - NIH
We found a small, statistically significant increase in the risk of gallbladder disease associated with desogestrel, drospirenone and norethindrone compared ...Missing: pregnancy hemolytic
[24]
Natural history of asymptomatic and symptomatic gallstones - PubMed
It appears that serious symptoms and complications develop in about 1% to 2% of patients with asymptomatic gallstones annually, with fewer complications ...
[25]
Acute Cholecystitis - StatPearls - NCBI Bookshelf - NIH
Jul 6, 2025 · Acute cholecystitis involves inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct by a gallstone.Continuing Education Activity · Etiology · Pathophysiology · Evaluation
[26]
Cholecystitis - Symptoms and causes - Mayo Clinic
Oct 23, 2024 · Cholecystitis (ko-luh-sis-TIE-tis) is swelling and irritation, called inflammation, of the gallbladder.
[27]
Biliary sepsis (cholecystitis & ascending cholangitis) - EMCrit Project
Oct 15, 2025 · Acalculous cholecystitis typically occurs in critically ill patients due to a combination of factors (e.g., bile stasis and hypoperfusion). This ...Missing: ischemia | Show results with:ischemia
[28]
Chronic Cholecystitis - StatPearls - NCBI Bookshelf
Chronic cholecystitis is a chronic condition caused by ongoing inflammation of the gallbladder resulting in mechanical or physiological dysfunction its emptying ...
[29]
Management of Gallstones and Their Complications - AAFP
Mar 15, 2000 · The clinical features of acute cholecystitis may include symptoms of local inflammation (e.g., right upper quadrant mass, tenderness) and ...Missing: pathophysiology | Show results with:pathophysiology
[30]
Functional gallbladder disorder in adults - UpToDate
May 9, 2024 · INTRODUCTION. Functional gallbladder disorder is characterized by biliary pain in the absence of gallstones, sludge, microlithiasis, ...
[31]
Functional Gallbladder Disorder: An Increasingly Common Diagnosis
May 15, 2014 · An ejection fraction less than 40% is abnormal. Because not all patients with suspected functional gallbladder disorder will benefit from ...
[32]
Biliary Dyskinesia - Is It Real? - PMC - NIH
Apr 3, 2025 · Biliary dyskinesia was defined as gallbladder EF <40% or >80% on HIDA-CCK, characterized as hypokinetic and hyperkinetic biliary dyskinesia, ...
[33]
Management of Incidentally Detected Gallbladder Polyps: Society of ...
Jul 5, 2022 · The vast majority of gallbladder polyps smaller than 10 mm are not true neoplastic polyps but are benign cholesterol polyps with no inherent ...
[34]
Outcomes of Gallbladder Polyps and Their Association With ...
May 18, 2020 · Surgical series indicate that the size of polyp is the major risk factor for malignancy, with adenomatous polyps of 10 mm and larger having a 37 ...
[35]
Diagnosis and Management of Gallbladder Polyps - PMC - NIH
In patients at risk for malignancy, a polyp of 6 mm or greater should likely be resected. Patients without risk factors are good candidates for EUS for further ...
[36]
Gallbladder Carcinoma - StatPearls - NCBI Bookshelf
Aug 17, 2024 · The prognosis for gallbladder cancer is generally poor, with a 5-year overall survival of less than 20%. Unfortunately, most cases are diagnosed ...Continuing Education Activity · Etiology · Epidemiology · Medical Oncology
[37]
Gallbladder carcinoma: Prognostic factors and therapeutic options
The outcome of gallbladder carcinoma is poor, and the overall 5-year survival rate is less than 5%. In early-stage disease, a 5-year survival rate up to 75% ...
[38]
Risk Factors for Gallbladder Cancer
May 16, 2025 · Gallstones are the most common risk factor for gallbladder cancer. Gallstones are pebble-like collections of cholesterol and other substances ...
[39]
https://www.cancer.org/cancer/types/gallbladder-cancer/about/key-statistics.html
[40]
Gallbladder agenesis a rare and underdiagnosed congenital anomaly
Nov 10, 2022 · Gallbladder agenesis (GA) is a rare and underdiagnosed congenital abnormality with prevalence of ~0.04–0.1% [2–6]. It affects females more than ...Missing: septations incidence
[41]
Prenatally diagnosed congenital agenesis of the gallbladder: A case ...
Gallbladder agenesis is a highly rare disorder with an incidence of 0.01–0.02% [5]. The condition can present at any age, with a mean age of diagnosis of 46 ...Missing: septations | Show results with:septations
[42]
Postcholecystectomy Syndrome - StatPearls - NCBI Bookshelf - NIH
Nuclear imaging such as a hepatobiliary iminodiacetic acid (HIDA) scan may demonstrate a biliary leak or help identify sphincter of Oddi dysfunction as a ...Etiology · Epidemiology · Evaluation · Treatment / Management
[43]
Postcholecystectomy Syndrome - Medscape Reference
Jul 16, 2024 · They also found that PCS was caused by functional disorders in 26% of patients, peptic disease in 4%, wound pain in 2.4%, stones in 1%, ...Practice Essentials · Pathophysiology and Etiology · Epidemiology
[44]
Choledocholithiasis - StatPearls - NCBI Bookshelf - NIH
Jaundice can occur in episodes. A patient with cholangitis also may have a fever, chills, and possibly altered mental status (Charcot triad or Reynolds pentad).
[45]
Biliary Colic: What It Is, Symptoms & Treatment - Cleveland Clinic
Mar 4, 2024 · Biliary colic is a pattern of periodic abdominal pain that's caused by an obstruction in your biliary tract, usually in your bile ducts or gallbladder.
[46]
Gallstones and gallbladder disease Information - Mount Sinai
Some patients with biliary colic experience the pain behind the breastbone. Nausea or vomiting may be present. Changing position, taking over-the-counter pain ...
[47]
Acute cholecystitis | Radiology Reference Article - Radiopaedia.org
Jul 31, 2025 · Acute cholecystitis is a common cause of hospital admission and is responsible for approximately 3-10% of all patients with abdominal pain.Gallbladder wall thickening · Acute cholecystitis · Gangrenous cholecystitis
[48]
Diagnosing Biliary Colic and Acute Cholecystitis - AAFP
Sep 15, 2000 · The classic Murphy's sign (abrupt interruption of deep inspiration) is elicited by palpation of the gallbladder area. A palpable mass caused by ...
[49]
Gallstones: Watch and wait, or intervene?
Apr 1, 2018 · Common symptoms of acute cholangitis include right upper quadrant pain, fever, and jaundice (Charcot triad), and these are present in about 50% ...
[50]
Acute cholangitis - an update - PMC - NIH
Although the presence of Charcot's triad is suggestive of acute cholangitis, it is not diagnostic. Charcot's triad is present in 26.4% to 72% of patients with ...
[51]
Upper abdominal pain: Gall bladder - PMC - PubMed Central - NIH
Pain arising from the gall bladder may be typical of biliary colic, but a wide variety of atypical presentations can make the diagnosis challenging.
[52]
Risk Factors for Delayed Diagnosis of Acute Cholecystitis among ...
Oct 4, 2022 · The symptoms of acute cholecystitis in older patients may be atypical and difficult to diagnose, causing delayed treatment. Clarifying the risk ...
[53]
Acute Cholecystitis Presenting With Septic Shock as the First ...
Jan 6, 2022 · In some patients with diabetes mellitus, acute cholecystitis can be complicated because of masked symptoms and delayed presentation, which can ...
[54]
Biliary Dyskinesia - PubMed
Patients with this condition present with biliary-type pain, and investigations show no evidence of gallstones in the gallbladder. The diagnosis is made by ...
[55]
PEDIATRIC CHOLELITHIASIS AND FACTORS ASSOCIATED WITH ...
Feb 17, 2025 · Cholelithiasis, characterized by hardened deposits in the gallbladder, presents symptoms such as abdominal pain, jaundice, nausea, and potential complications.Colelitíase Pediátrica E... · Abstract · DiscussionMissing: elderly | Show results with:elderly
[56]
Gallbladder cancer - Symptoms and causes - Mayo Clinic
Jul 31, 2024 · Gallbladder cancer is a growth of cells that begins in the gallbladder. The gallbladder is a small, pear-shaped organ on the right side of the belly, just ...
[57]
Diagnosis of Gallstones - NIDDK
Overview of how doctors diagnose gallstones using lab tests and imaging tests such as an ultrasound, CT scan, MRI, cholescintigraphy, or ERCP procedure.
[58]
Overuse of Computed Tomography in Patients with Complicated ...
In summary, our study demonstrates the overuse of CT in the evaluation of patients with acute gallbladder disease despite being of little additional benefit ...<|control11|><|separator|>
[59]
Evidence-Based Current Surgical Practice: Calculous Gallbladder ...
DIAGNOSTIC IMAGING · Right upper quadrant ultrasound · Computed tomography (CT) · Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography ...
[60]
Noninvasive Imaging of the Biliary System Relevant to ...
Ultrasound image shows gallbladder wall thickening (solid white arrow) ... US, CT, and MRI play complementary roles in the imaging of biliary tract disease.
[61]
Evaluation and Management of Gallstone-Related Diseases in Non ...
Ultrasonography of the gallbladder detects gallstones with >95% sensitivity and specificity, confers no ionizing radiation, is noninvasive, readily available, ...Missing: techniques | Show results with:techniques
[62]
Biliary Obstruction - StatPearls - NCBI Bookshelf - NIH
Elevation of bilirubin is generally in the form of conjugated hyperbilirubinemia. Important diagnostic tests include abdominal ultrasound, CT scan of the ...
[63]
Approach To A Patient With Elevated Serum Alkaline Phosphatase
An elevated serum bilirubin is an independent predictor of survival. However, the hallmark of PBC is presence of AMA which is positive in 90–95% of ...
[64]
Acute Cholecystitis Presenting With Atypical Radiologic or ... - NIH
Jun 30, 2023 · A positive Murphy's sign on physical exam, RUQ pain, fever, and leukocytosis indicate cholecystitis.
[65]
Acute Cholecystitis Workup - Medscape Reference
Jul 13, 2022 · Findings suggestive of acute cholecystitis include wall thickening (>4 mm), pericholecystic fluid, subserosal edema (in the absence of ascites), ...
[66]
C-reactive protein in gallbladder diseases: diagnostic and ...
Jun 17, 2020 · CRP levels are reported to be of value in diagnosing acute cholecystitis severity, in predicting the outcome and prognosis of cancer-associated gallbladder ...Crp As The Prototypic... · Crp As A Diagnostic Marker... · Discussion
[67]
Acute Cholangitis Workup - Medscape Reference
Nov 30, 2023 · Blood cultures (2 sets): Between 20% and 30% of blood cultures are positive. Many exhibit polymicrobial infections. Urinalysis result is ...
[68]
Cholecystitis - Diagnosis and treatment - Mayo Clinic
Oct 23, 2024 · Treatment for cholecystitis most often involves a hospital stay to control the swelling and irritation, called inflammation, in your gallbladder.
[69]
Bile Acid Malabsorption: Symptoms, Causes & Treatment
Oct 19, 2022 · The fecal BA test measures levels of bile acids excreted in your poop. This may be the most direct way of measuring bile acid malabsorption.
[70]
Open Cholecystectomy - StatPearls - NCBI Bookshelf - NIH
... recovery time from several weeks to about one week. General contradictions for any surgery, in general, apply to open cholecystectomy. Severe comorbid ...Continuing Education Activity · Introduction · Indications · Contraindications
[71]
Cholecystectomy (gallbladder removal) - Mayo Clinic
Apr 15, 2025 · A cholecystectomy is a common surgery. It is a safe operation and usually carries only a small risk of complications.
[72]
What necessitates the conversion to open cholecystectomy? A ... - NIH
The overall rate of conversion to open cholecystectomy was 3.16% (163 patients). There were 84 male and 79 female patients; the mean age was 52.04 years.
[73]
Percutaneous Cholecystostomy: Background, Indications, Outcomes
Nov 16, 2023 · Cholecystostomy is used as a temporizing measure in critically ill patients with acute cholecystitis who cannot undergo cholecystectomy.
[74]
Percutaneous Cholecystostomy: Evidence-Based Current Clinical ...
Studies have shown PC to be an effective treatment for resolving acute cholecystitis in up to 90% of patients and the definitive treatment in up to 54% of ...
[75]
Choledocholithiasis: Evaluation, Treatment, and Outcomes - PMC
Although ERCP is most commonly utilized to manage choledocholithiasis, it carries an overall complication rate of 8 to 12%, with a major complication rate ...
[76]
Guidelines for the Clinical Application of Laparoscopic Biliary Tract ...
Acute cholecystitis: Early cholecystectomy (within 24-72 hours of diagnosis) may be performed without increased rates of conversion to an open procedure, ...
[77]
Optimal Timing of Cholecystectomy for Acute Cholecystitis - NIH
Aug 29, 2022 · Urgent laparoscopic cholecystectomy performed within 24 hours of hospital admission for acute cholecystitis decreased hospital cost, LOS, and ...
[78]
https://pmc.ncbi.nlm.nih.gov/articles/PMC5088099/
[79]
Management of Gallstones - AAFP
Aug 15, 2005 · Watchful waiting is indicated for most patients with asymptomatic gallstones. C. Patients with biliary pain should have laparoscopic ...Abstract · Surgical Treatment of... · Management of Common...
[80]
Surgical and Nonsurgical Management of Gallstones - AAFP
May 15, 2014 · Percutaneous cholecystostomy is an alternative for patients who are critically ill with gallbladder empyema and sepsis. Cholelithiasis, or ...
[81]
The Effect of Ursodiol on the Efficacy and Safety of Extracorporeal ...
Nov 1, 1990 · Extracorporeal shock-wave lithotripsy with ursodiol was more effective than lithotripsy alone for the treatment of symptomatic gallstones, and equally safe.
[82]
Nonsteroidal anti‐inflammatory drugs (NSAIDs) and non‐opioids for ...
Jun 29, 2015 · Antispasmodic medications are sometimes used alone or in combination with other analgesics for treatment of acute renal colic and work by ...
[83]
Acute Cholecystitis Treatment & Management - Medscape Reference
Jul 13, 2022 · Prophylactic antibiotic coverage with levofloxacin (Levaquin, 500 mg PO qd) and metronidazole (500 mg PO bid), which should provide coverage ...Initial Therapy and Antibiotic... · Conservative Treatment of... · Cholecystectomy
[84]
Eating, Diet, & Nutrition for Gallstones - NIDDK
Eat healthy fats, like fish oil and olive oil, to help your gallbladder contract and empty on a regular basis. Avoid unhealthy fats, like those often found in ...
[85]
Gallbladder perforation: morbidity, mortality and preoperative risk ...
Introduction: Gallbladder perforation (GBP) is a life threatening complication of acute cholecystitis occurring in approximately 2-11 % of patients.
[86]
Empyema of the Gall Bladder: Reappraisal in the Laparoscopy Era
Aug 10, 2025 · Furthermore, empyema of the gallbladder has a reported incidence of 2-11% with an associated higher risk of mortality, which can also be ...<|separator|>
[87]
Mirizzi Syndrome—The Past, Present, and Future - MDPI
Mirizzi syndrome is a rare complication of gallstone disease, with a variable incidence of 0.3% to 1.4% in Europe and the United States of America, 4.7% in ...
[88]
Cholangitis - StatPearls - NCBI Bookshelf - NIH
The definitive diagnosis of acute cholangitis would include systemic signs of infection as well as confirmatory evidence of purulent bile by endoscopic, ...
[89]
Etiology of acute pancreatitis - UpToDate
Jan 6, 2025 · Gallstones (including microlithiasis) are the most common cause of acute pancreatitis accounting for 40 to 70 percent of cases.
[90]
Bile Duct Injury - StatPearls - NCBI Bookshelf - NIH
The rate of bile duct injury in laparoscopic cholecystectomy is less than 1%, which limits the ability to collect enough data through randomized controlled ...Continuing Education Activity · Epidemiology · Evaluation · Treatment / Management
[91]
analysis of 5675 laparoscopic cholecystectomies
Aug 26, 2021 · The incidence of post-cholecystectomy bile leakage (PCBL) other than from major ductal injury is 0.3–2.7% of patients undergoing laparoscopic ...
[92]
Risk Factors for Surgical Site Infection After Cholecystectomy
Feb 22, 2017 · Surgical site infections were identified after 472 of 66566 (0.71%) cholecystectomies; incidence ... surgical wound infection. Issue Section ...
[93]
TG13 current terminology, etiology, and epidemiology of acute ...
Jan 11, 2013 · After 2000, the mortality rate of acute cholangitis has been about 10 %, while that of acute cholecystitis has generally been less than 1 %.
[94]
The Symptomatic Outcomes of Cholecystectomy for Gallstones - MDPI
Feb 28, 2023 · Following cholecystectomy, resolution of biliary pain is high and reported for 66–100%. Dyspepsia has an intermediate resolution of 41–91% and ...
[95]
Chronic diarrhea: A concern after gallbladder removal? - Mayo Clinic
Studies have found that up to 20% of people undergoing gallbladder surgery develop diarrhea. In most cases, the diarrhea stops soon after the surgery.Missing: rate | Show results with:rate
[96]
Medline ® Abstracts for References 20,75,76 of 'Overview of ...
RESULTS The 3-, 5- and 7-year cumulative probabilities of gallstone recurrence were 20.6, 27.1 and 33.1%, respectively, with the recurrence probability ...
[97]
Risk Factors for Incidental Gallbladder Cancer Found During ...
Although gallbladder cancer (GBC) is rare with an incidence of 0.6% of all cancer diagnoses, it has a 73% case-fatality rate. Despite improved diagnostic ...
[98]
Evaluation and management of incidental gallbladder cancer - Zaidi
Aug 27, 2019 · GBC is an aggressive malignancy with poor outcomes and a 5-year survival that ranges between 5–12% (3). Although many patients with GBC present ...
[99]
Acute Cholecystitis: Practice Essentials, Background, Pathophysiology
Jul 13, 2022 · In patients who are critically ill with acalculous cholecystitis and perforation or gangrene, mortality can be as high as 50%-60%. The severity ...Practice Essentials · Background · Pathophysiology · Etiology